Virtual Pitching and Networking Event – 26 June, 2019 3:00 PM CEST

In the frame of the IRSUS project, we organise our first Virtual Pitching and Networking Event, with pitches of pre-selected, high potential projects especially from the Healthcare industry. We highly welcome all interested participants, potential investors, from the field.

The projects were validated in the frame of the IRSUS project by innovation management experts. We expect the participation of business angels, venture capitalists investing all over Europe. SMEs from all industries are also welcome to to create  partnerships (main domain: Health, Biotech).

The participation is free, but registration is expected.  Please register through this link. The participation is free.

Date of the webinar: 26 June, 2019 3:00 PM CEST

Expected pitches

Defymed

French company looking for Serie A investment

Defymed develops two innovative medical devices that physiologically deliver therapeutics to improve clinical efficacy and patients’ comfort, with a first focus on Diabetes: MailPan®, a cell encapsulation device and ExOlin® a targeted drug-delivery device.

More information:  http://www.defymed.com

Askel Healthcare Oy

Finnish company looking for Serie A investment

Askel Healthcare brings you the best solution to regenerate cartilage: COPLA® Scaffold is tailored to adapt to the specific conditions of weight-bearing joints to fully regenerate cartilage for pain-free movement.

More information: https://www.askelhealthcare.com

Mando Group AB

Swedish company looking forSerie A investment

Mando Group AB is a research-based SME that manages under- and overweight patients by evidence-based treatments, including computer-assisted restoration of eating behaviour, using Mandometer. Mandometer is a patented FDA-cleared medical device, that will now be used to prevent obesity.

More information: https://mando.se/en/

Novago Therapeutics AG

Swiss company looking for Serie B investment

Novago Therapeutics is a biotech dedicated to the development of therapeutics that promote nerve repair and regeneration in the treatment of stroke and spinal cord injury.

More information: http://www.novagotherapeutics.com

If you are interested, please register here, the participation is free!

In case you have any question or need more information feel free to contact us through info@irsus.eu

Share this post

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Related posts

Regiothek was heading to the Global Food Summit 2019

One of our portfolio companies, Regiothek (www.regiothek.de), is one of five Start-Ups worldwide, presenting its innovation at the Global Food Summit in Munich, Germany. The Global Food Summit is a scientific conference featuring innovations in the food sector. Regiothek is the very first online platform for local food which is actually assessing the regionality or

Read more »

IRSUS Open Call was a great success!

The IRSUS Open Call closed on the 31st of March with 185 applicants from 29 countires! We aimed to find innovative companies and entrepreneurs, who want to enter the market with their products and services contributing to the competitiveness of Europe. The open call aimed to collect innovators and  help the selected startups with mentoring,

Read more »
open call irsus

IRSUS launches a new call for startups

Until the end of March, we are open for applications of startups from all over Europe. We want successful startups in previous H2020 initiatives to join our programme. Our claim is “we want your success not your equity” and we really mean it. Filling a simple Google Form we will offer free assistance to tech

Read more »

About Us

The Innovation Radar (IR) is an EC initiative focused on the identification of high potential innovations and the key innovators behind them in FP7, CIP and Horizon 2020 projects. It supports innovators by suggesting a range of targeted actions to assist them in fulfilling their potential in the market.

Contact

Follow Us

Search

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779990

logo_transp_02
© 2018 IRSUS All rights Reserved